ArticleJournal of hepatocellular carcinoma2023

Lenvatinib Induces Immunogenic Cell Death and Triggers Toll-Like Receptor-3/4 Ligands in Hepatocellular Carcinoma.

Cheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.